Overview:

The orthopaedic bone cement and casting material market is set for notable expansion over the next ten years. Projections suggest the market, valued at approximately USD 3.2 billion in 2025, will climb to around USD 5.4 billion by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of roughly 5.3% throughout the forecast period, highlighting a stable and continuous demand for these essential orthopaedic products.

This steady market progression between 2025 and 2035 is underpinned by several critical factors. Foremost among these is the increasing global prevalence of conditions like osteoarthritis, osteoporosis, and various traumatic injuries. These health challenges, when combined with the steadily increasing demographic of older individuals around the world, collectively fuel the constant need for orthopaedic interventions requiring both bone cement and casting materials.

Bone cements are primarily employed in surgical procedures to stabilize implants during joint replacements, particularly in total hip and knee arthroplasties. They also serve a vital role in addressing bone deficiencies. In parallel, casting materials are integral to the non-surgical management of fractures, providing critical immobilization for effective healing.

Growth is also being stimulated by the rising number of orthopaedic surgeries in developing nations. Innovations in materials science, such as the development of bone cements infused with antibiotics to combat infection and lightweight, resilient fiberglass casting options, are contributing significantly to market expansion. Furthermore, the trend towards outpatient surgical centers and less invasive procedures is increasing the demand for materials that set quickly and are highly biocompatible.

Historically, the market relied heavily on basic plaster of Paris and conventional polymeric compounds. Early products focused on simple fracture support and implant fixation, gradually evolving towards more advanced, higher-performing options as clinical needs became more complex.

Increased surgical volumes in joint reconstruction and trauma care have particularly spurred the development of cements incorporating antibiotics, aimed at reducing post-operative infection risks. Concurrently, advancements in casting technology have resulted in fiberglass and thermoplastic materials offering superior durability, enhanced patient comfort, and improved X-ray visibility.

The prevailing shift toward less invasive procedures and ambulatory care settings has further refined product requirements. Contemporary surgical materials must be fast-curing, biocompatible, and designed for ease of use, reflecting a broader industry transition from basic utility to precision-focused orthopaedic solutions.